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The early preimplantation mouse embryo is a unique system where it is possible to explore the foundations of totipo-
tency and differentiation. Following fertilization, a single cell, the zygote, will give rise to all tissues of the organism.
The ﬁrst signs of differentiation in the embryo are evident at the blastocyst stage with the formation of the trophecto-
derm, a differentiated tissue that envelopes the inner cell mass. The question of when and how the cells start to be
different from each other in the embryo is central to developmental biology: as cell fate decisions are undertaken,
loss of totipotency comes about. Although the blastomeres of the preimplantation embryo are totipotent, as the
embryo develops some differences appear to develop between them which are, at least partially, related to the epigenetic
information of each of these cells. The hypothesis of epigenetic asymmetries acting as driver for lineage allocation is
presented. Although there are now some indications that epigenetic mechanisms are involved in cell fate determination,
much work is needed to discover how such mechanisms are set in play upon fertilization and how they are transmitted
throughcelldivision.Theseconsiderationsarefurtherdiscussedinthecontextofpreimplantationgeneticdiagnosis:does
it matter to the embryo which cell is used for genetic diagnosis? The exquisite complexity and richness of chromatin-
regulated events in the early embryo will certainly be the subject of exciting research in the future.
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Embryonic development starts from a single cell, the zygote. In
this cell, the two gametes convey and contribute information to
start a new developmental programme. The formation of the
newly fertilized zygote constitutes therefore the climax of toti-
potency because of the resulting zygote’s inherent ability to
produce all cell types in a new organism.
In the mammalian embryo, the ﬁrst differentiative event
occurs as inner cells form upon cell division at the 8-cell
stage. As a result of this division, an ‘inner’ and an ‘outer’
population of cells can be distinguished in the 16-cell stage
embryo, which will respectively occupy different positions in
the morula (Johnson and Ziomek, 1981). Much work has
been done in trying to understand how cell polarity develops
in the inner and outer cells, but I will not deal with this topic
here and instead will refer the reader to an excellent review
published elsewhere (Johnson and McConnell, 2004). The
inner cells will develop into the inner cell mass (ICM) and
the outer layer of cells will differentiate into the trophectoderm
(Tarkowski and Wroblewska, 1967; Ziomek and Johnson,
1982). Morphologically, however, the ﬁrst overt signsof differ-
entiation are evident only at the blastocyst stage, with the for-
mation of the trophectoderm, which is the ﬁrst differentiated
tissue to form as an epithelial layer that envelops the ICM
(Fig. 1A). The latter, in contrast to the trophectoderm, retains
its pluripotent character and the ability to self renew. While
the ICM will give rise to the embryo proper, the trophectoderm
will give rise to the extraembryonic tissues that will support
development of the embryo during gestation. The ICM will
also give rise to yet another extraembryonic tissue, the primi-
tive endoderm, which is ﬁrst visible as a cuboidal layer of
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opment. The trophectoderm and the ICM each display molecu-
lar identity, which is reﬂected in part by the expression of
speciﬁc genes that are, for the ICM, involved in its speciﬁca-
tion and the maintenance of pluripotency (such as Nanog and
Oct4) or, for the trophectoderm, that are required for its differ-
entiation (such as Cdx2) (Palmieri et al., 1994; Nichols et al.,
1998; Chambers et al., 2003; Mitsui et al., 2003; Strumpf
et al., 2005). The bifurcation of these two lineages is complete
at the late blastocyst stage. At this stage, cells from the ICM do
no longer have the potential to form trophectoderm derivates in
vivo upon transplantation (Rossant and Lis, 1979), indicating
that these cells have lost their totipotency and that lineage allo-
cation has deﬁnitely occurred.
Investigations during recent years have recreated an interest
in whether the blastomeres of the mammalian embryo are truly
alike throughout preimplantation development before the ﬁrst
differentiative division mentioned above. In other words,
whether they acquire a ‘fate’ or whether they start to differ
from each other prior to their spatial ‘inner/outer’ allocation
Figure 1: Cell lineages of the mammalian blastocyst and epigenetic marking
(A) Representation of the lineages in the mammalian blastocyst on the third day of gestation (E3.5). The blastocyst is composed of two distinct
populations of cells: the trophectoderm (red) and the inner cell mass (ICM, green), which display molecular identity and epigenetic asymmetries.
The embryonic-abembryonic regions (dotted line) of the blastocyst are determined by the position of the ICM, which lies within the embryonic
region of the blastocyst. (B) Diagram illustrating some of the epigenetic marks. The DNA wrapped around the nucleosome (beige cylinders) is
shown as light blue. The DNA is subject to DNA methylation, which constitutes one of the main epigenetic players. The core histones (beige) that
form the nucleosome can be covalently modiﬁed (by acetylation, methylation, phosphorylation), particularly on their N-terminal tails. Each of
these marks can have an effect on how the information contained in the DNA is read by modulating downstream events such as transcriptional
activation or repression. For example, histone methylation (Me) can have a positive effect on transcription (green) or a repressive one (red). The
marks can be present in different combinations and may change during the cell cycle. (C) Model for epigenetic marking and lineage allocation. In
this model, an epigenetic mark would be laid down in a given cell during development. There could be other epigenetic event(s) that reinforce
and/or are inﬂuenced by the ﬁrst marking event. Cumulatively, this could result in determination of the fate of that cell towards a lineage in the
blastocyst. The lineage speciﬁc marks could stabilize such cell identity and might be necessary for further differentiation. Alternatively, the acqui-
sition of these epigenetic marks could be the result of cell fate determination. One should also consider that not only the nature of the mark would
be important, butalso the different regions of the chromatin that would be affected by such marks. Because the cells in the preimplantation embryo
are totipotent and because the chromatin will still need to be dynamically remodelled during subsequent development, ﬂexibility should be an
important component of epigenetic mechanisms taking place during early development. As cell fate decisions are taken, a concomitant loss of
totipotency takes place
Epigenetics and cell fate
1247within the embryo upon the formation of the morula. Of course,
if this were to be the case, the big challenge would be to ascribe
molecular mechanisms to these processes.
The question of when and how the cells start to be different
from each other is not a trivial one. In particular, because as
the ﬁrst cell fate decisions are undertaken, a concomitant
loss of totipotency occurs. The developmental time window
when this ﬁrst cell fate decision occurs comprises a number
of epigenetic events (Morgan et al., 2005; Surani et al.,
2007). These events include the reprogramming of the par-
ental chromatin. Whether such epigenetic events are the
cause or the consequence of reprogramming remains an excit-
ing open question, but it is probably a combination of the two.
Moreover, the two lineages of the blastocyst exhibit some epi-
genetic asymmetries.
This mini-review is divided in two parts, the ﬁrst one will
deal with the main epigenetic mechanisms that are known to
occur during mammalian preimplantation development. The
second one will give an overview on data obtained through
experimental embryology manipulations and lineage tracing
observations to study cell fate in the early mouse embryo.
Epigenetic mechanisms in the preimplantation embryo
In general terms, epigenetic mechanisms include DNA methyl-
ation, covalent modiﬁcation of histones, chromatin remodel-
ling and histone replacement through incorporation of the
so-called histone variants (Fig. 1B). Histone marks have
emerged as one of the main players involved in epigenetic
mechanisms (Kouzarides, 2007). Histone modiﬁcations can
be highly dynamic, or have a function in epigenetic memory.
Although it is still unclear whether they are the actors of the
epigenetic information or the epigenetic information itself, it
is evident that covalent modiﬁcations of histones are essential
components of the epigenome.
Histones can be modiﬁed by a number of enzymes that
mediate methylation, acetylation, phosphorylation, ubiquityna-
tion and ADP-ribosylation of speciﬁc amino acid residues
(reviewed in Kouzarides, 2007). By and large, the highest
density of modiﬁcations so far described occurs in histone
H3, particularly on its tail. The effects of these modiﬁcations
on the chromatin and on cellular processes are very diverse,
and a modiﬁcation of the same residue can even have opposite
effects depending on the type of modiﬁcation. For example, tri-
methylation of H3K9 is considered as a repressive mark,
whereas acetylation of the same lysine has a positive effect
on transcription (Bannister and Kouzarides, 2005). Likewise,
methylation of arginine residues can have a positive effect on
transcription (Chen et al., 1999) or a repressive effect (Pal
et al., 2004), depending both on the targeted residue and on
whether the methylation is symmetric or asymmetric. For
some of the modiﬁed residues, there is a very clear view of
the outcome of an eventual modiﬁcation: H3K9me3 creates a
speciﬁc docking site for the heterochromatin protein 1 (HP1),
which subsequently recruits the H3K9 methyltransferase
Su(var)3-9 and reinforces an autoregulatory loop for hetero-
chromatin formation and maintenance (Bannister et al., 2001;
Lachner et al., 2001; Nakayama et al., 2001).
The levels of regulation of epigenetic events in the preim-
plantation mouse embryo are multiple. They include the regu-
lation of the subcellular localization of DNA methyltransferase
activity, highlighted by the cytoplasmic retention of Dnmt1o
(Carlson et al., 1992); the exclusion of a particular histone
modiﬁcation from the chromatin, which is exempliﬁed by the
lack of detection of H3K9me3 in the paternal pronucleus
after fertilization resulting in an asymmetry of histone marks
between the two pronuclei (Arney et al., 2002; Santos et al.,
2005), the differential incorporation of chaperons and histone
variants in the parental chromatin (van der Heijden et al.,
2005; Torres-Padilla et al., 2006) and the acquisition of
highly speciﬁc histone variants in the gametes (Clarke et al.,
1992; Tanaka et al., 2001; Govin et al., 2007). Further, the
maternal and paternal pronuclei exhibit different patterns of
global DNA methylation: while the paternal pronucleus is
rapidly demethylated—presumably through an active
mechanism—right after fertilization, the maternal pronucleus
is only passively demethylated through the subsequent
rounds of replication and cell division that follow the ﬁrst
mitosis of the embryo (Mayer et al., 2000). Moreover, while
the centromeric and pericentric paternal chromatin remain
DNA methylated, the maternal DNA loses methylation in
such regions (Rougier et al., 1998).
The changes in the levels of DNA methylation as develop-
ment proceeds in the preimplantation embryo are dynamic.
Global levels of DNA methylation have been analysed by
immunoﬂuorescence, bisulphate sequencing and restriction
digestion (Rougier et al., 1998; Mayer et al., 2000; Santos
et al., 2002; Aranyi and Paldi, 2006). Bisulphate sequencing
and restriction digestion have also been used to analyse the
methylation status of repeat sequences (such as L1 and IAP
repeats) and some single-copy sequences (such as actin)
(Howlett and Reik, 1991; Oswald et al., 2000). These studies
have revealed that although global levels of DNA methylation
decrease until the blastocyst stage, changes in DNA methyl-
ation do not occur to the same extent on all genes. Remarkably,
imprinted genes (such as H19) and some repeat sequences
(such as IAPs) do not undergo demethylation (Tremblay
et al., 1997).
During early stages of development, decisions involved in
cell fate determination and pluripotency have to be assumed.
These processes require the chromatin to be dynamically remo-
delled to ensure its plasticity. This implies that the mechanisms
involved in regulation of chromatin structure need to ensure
stability across generations and cell division, but they also
need to be ﬂexible (Reik, 2007). The double nature of a
covalent modiﬁcation either on histones and/or on the DNA
as dynamic (because in principle it can be added and
removed) and at the same time its potential ability to propagate
a memory, ﬁts well with these aforementioned needs. More-
over, in keeping with the importance of epigenetic mechanisms
during early development, the possibility for an epigenetic
mark(s) underlying these phenomena appears very attractive.
Concerning the epigenetic asymmetries of the ICM and the
trophectoderm, the ICM displays, in global terms, higher
levels of DNA methylation compared with the trophectoderm
(Dean et al., 2001; Santos et al., 2002). Speciﬁc histone
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(H3K9me3 and H3K27me3, respectively) are enriched in the
ICM compared with the trophectoderm (Erhardt et al., 2003).
Likewise, the trophectoderm retains an imprinted form of X
inactivation, where the paternal X chromosome is silenced
(Heard and Disteche, 2006). This is in contrast to the ICM,
where there is reactivation of the inactive X chromosome and
a subsequent round of inactivation occurs at random in which
either the maternal or the paternal chromosome is inactivated
(Mak et al., 2004; Okamoto et al., 2004).
The aforementioned epigenetic asymmetries of the two
lineages of the blastocyst are evident once lineage allocation
has taken place and might reinforce their molecular identity.
However, epigenetic asymmetry could also act as a driver for
lineage allocation, in which case, the former would precede
the latter (Fig. 1C). This constitutes a fascinating current
working hypothesis.
Development of cell identity in the mouse embryo
From experimental embryology, we have learnt from pioneer
experiments performed in the 50’s that after mechanical separ-
ation of the blastomeres of a 2-cell stage embryo and transfer
into foster mothers, each of these two cells gives rise to an
adult mouse (Tarkowski, 1959). This indicates that mouse
embryos are very ﬂexible in what people have referred to as
developmental potential. Derivation of twins from mouse blas-
tomeres at later stages of development (e.g. 4-cell stage or
later) has not been possible. Although this has been linked to
the low number of cells present in the resulting embryos and
hence their inability to form an ICM with a normal cell
number, rather than to their developmental potential or identity
(Tarkowski and Wroblewska, 1967; Rossant, 1976). Indeed,
when random single 4- and 8-cell stage blastomeres are aggre-
gated with ‘carrier’ blastomeres, their progeny is able to con-
tribute to all the tissues of the embryo (Kelly, 1977;
Tarkowski et al., 2005), and in this sense, the blastomeres
were considered to be totipotent. So, what are these carrier
cells providing? Is it a simple matter of cell number? and/or
of an appropriate environment? It is also possible however
that some subtle intrinsic differences of these blastomeres
might be masked by the limitations of the outcome of trans-
plantation procedures, given that the results of these studies
are very often far from 100% and the transplantation efﬁciency
is never absolute. Whether this is solely related to technical dif-
ﬁculties linked to these challenging manipulations or to an
intrinsic property of speciﬁc blastomeres of the embryo is
impossible to ascertain.
Despite a controversial viewpoint on whether there is any
polarity in the early mouse embryo or not, most reports
coincide with the interpretation that a blastomere at the 2-cell
stage contributes to both the ICM and the trophectoderm
(reviewed in Edwards and Beard, 1997; Zernicka-Goetz,
2006). The suggestion of a given blastomere at the 2-cell
stage having a ‘preferential’ fate towards either of the blasto-
cyst lineage is not resolved and some researchers have
suggested that a slight, but distinct difference in the fate of
2-cell stage blastomeres might be disturbed by experimental
manipulations (Alarcon and Marikawa, 2005; Hiiragi et al.,
2006). The role of extrinsic factors to the embryo, such as
the shape of the zona pellucida, in axis speciﬁcation of the blas-
tocyst is also a matter of controversy (Gardner, 2007; Kurotaki
et al., 2007). However, there are some indications that a bias
for a blastomere to contribute to a given region of the
embryo in the blastocyst could already exist at the 4-cell
stage (Fujimori et al., 2003; Piotrowska-Nitsche and
Zernicka-Goetz, 2005). These conclusions are mostly
based on lineage tracing experiments of labelled blastomeres,
and their degree of invasiveness is debatable.
Some groups have used the plane of division in relation to
the animal–vegetal axis of the embryo as a sort of guideline
to distinguish and characterize blastomeres according to their
cleavage plane. By convention, the animal pole is demarcated
by the position of the second polar body (which is extruded
after resumption of meiosis II upon fertilization) and hence
the vegetal pole lies on the opposite side (Fig. 2A). The div-
ision from the 2- to the 4-cell stage would segregate for the
ﬁrst time the ‘animal’ and the ‘vegetal’ components of
the zygote if it occurs equatorially, that is, perpendicular to
the animal–vegetal axis of the conceptus (Gardner, 2002).
Thus, whereas a cell that derives from a meridional division
(parallel to the animal–vegetal axis) inherits both components,
an equatorial division gives rise to an ‘animal’ and a ‘vegetal’
blastomere (Fig. 2B). By looking into the plane of division and
the order at which this division occurs from the 2- to the 4-cell
stage and subsequent lineage tracing, a subgroup of embryos
was identiﬁed where it is possible, with a relatively high prob-
ability, to predict the future position of the blastomeres in the
blastocyst (Piotrowska-Nitsche et al., 2005). This group of
embryos are referred to as ME embryos (for Meridional–
Equatorial, reﬂecting the type of cleavage plane and order of
Figure 2: Blastomere division planes according to the animal-vegetal
axis in the embryo
(A) The animal–vegetal (A–V) axis of the preimplantation embryo is
demarcated, by convention, by the position of the second polar body,
which marks the animal pole. The opposite side to the site of extrusion
of the polarbodyis, bydefault,the vegetal poleof the embryo.(B) The
division pattern from 2-to- 4-cell stage of a typical embryo that under-
goes one meridional (M) and one equatorial (E) division (ME embryo)
is represented. The cleavage plane is depicted by a red dashed line
(embryo on the left). The blastomere that divides earlier is represented
on the left. A Meridional division has a cleavage plane that is parallel
to the A–V axis of the embryo and hence gives rise to two cells con-
taining both ‘animal’ and ‘vegetal’ components (two cells with pink
and yellow motifs on the embryo depicted on the right). In contrast,
when a 2-cell stage blastomere divides equatorially, a segregation of
the ‘animal’ and ‘vegetal’ cytoplasm occurs and follows derivation
of an ‘animal’ (pink) and a ‘vegetal’ (yellow) blastomere
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et al., 2005; Piotrowska-Nitsche and Zernicka-Goetz, 2005).
Although the ME type embryos constitute only a small part
(20%) of a complete litter, they provide a very nice system
where it is possible to explore the foundations of differentiation
in the embryo. Indeed, the ‘vegetal’ blastomere would most
often populate the abembryonic region of the blastocyst,
which contains mainly mural trophectoderm.
In looking for epigenetic marks that could be involved in an
eventual cell fate decision of the blastomeres of these ME
embryos, it was found that the ‘vegetal’ blastomere displays
the lowest levels of dimethylated arginine 26 of H3
(H3R26me2). If H3R26me2 participates in lineage allocation,
one might predict that modulating the levels of histone arginine
methylation, would have an effect over cell fate. Overexpres-
sion of the histone methyltransferase that methylates this
residue on H3, PRMT4/CARM1, into individual blastomeres
not only induced upregulation of Nanog and Sox2, but also
resulted in an almost complete allocation of these blastomeres
into the ICM compartment (Torres-Padilla et al., 2007).
It is interesting to note that in the mouse, the differences
described in histone H3 arginine methylation appear at the
4-cell stage (Torres-Padilla et al., 2007), that is. as early as
one cell cycle after the major wave of embryonic genome acti-
vation occurs (Schultz, 2002; Hamatani et al., 2004), which
suggests that these events might be, at least in part, linked to
the transcriptional programme of the embryo. The develop-
mental stage at which genome activation occurs in other
mammalian species varies considerably: it takes place at the
1-to- 2-cell stage in mice, the 4-to- 8-cell stage in cows and
humans, and the 8-to- 16-cell stage in sheep and rabbits
(Schultz and Heyner, 1992). Would this anticipate a different
timing for an eventual ‘cell fate path’ for other species?
Normal fertile adults can be derived from single blastomeres
from 2-, 4- and 8-cell stage embryos in the rabbit, sheep and
cattle (Moore et al., 1968; Willadsen, 1981; Willadsen and
Polge, 1981). Thus, these species indeed support blastomere
isolation and further development at later stages than the
mouse does.
Transplantation of isolated 4-cell blastomeres into morula
stage embryos has demonstrated that the blastomeres at the
4-cell stage are totipotent (Kelly, 1977). In this context, it is
important to note that aggregating the ‘vegetal’ cell from ME
embryos to form chimeric embryos, showed that this cell is
able to contribute to all tissues in the embryo. However, aggre-
gating the same blastomere with other ‘vegetal’ blastomeres
from ME embryos exclusively, results in a failure to proceed
through development (Piotrowska-Nitsche et al., 2005). Thus,
the environment where the blastomeres develop is crucial for
the success of the embryo throughout development, and in a
‘normal’ situation, where the embryo has not been perturbed
and a given cell develops in its niche, some differences
appear to develop, which are, at least partially, related to the
epigenetic information of each of them (Torres-Padilla et al.,
2007). If epigenetic asymmetries of the early embryo are
related to lineage allocation, it is still uncertain whether they
are a cause or a consequence for lineage choice. Also, it
remains unknown whether such epigenetic asymmetries
would affect only particular regions of the genome. For
example, whether genes involved in speciﬁcation of the ICM
such as Sox2 and Nanog would all be targeted by the same epi-
genetic marks in the same blastomere or whether such marks
would vary among genes and/or among blastomeres. Further,
are ‘inner’ and ‘outer’ cells at the 16-cell stage distinguishable
in terms of their chromatin landscapes?
The experiments showing that blastomeres are able to
respond to the overexpression of a histone modiﬁer and
change their fate, indicate that these cells have not yet acquired
a ‘ﬁx’ destiny, but that they can still be responsive to some kind
of signals. These experiments have an important impact on
showing that manipulating the epigenetic information can
affect cell fate in the preimplantation embryo, in line with the
importance of epigenetic mechanisms being crucial for early
development. Moreover, these results do illustrate that such
cells can still be ﬂexible and accommodate themselves after a
perturbing event (in this case, overexpression of a histone
methyltransferase and the downstream effects on the infor-
mation that is. imparted through speciﬁc histone modiﬁcations).
These studies have originated some interest from the part of
the medical community, particularly, in the context of preim-
plantation genetic diagnosis (PGD) (Goldman, 2007). Does it
matter to the embryo which cell is used for genetic diagnosis?
Might the death of one of these cells have an effect on sub-
sequent development? This question is equally valid on the
impact of cell loss upon cryopreservation (Cohen et al.,
2007). Although these are very delicate questions with very
likely no easy answer, from the perspective of the mouse
embryo, at least four things are to be considered. A tendency
for a blastomere of some 4-cell stage embryos to contribute
to a given region of the embryo has been documented.
Second, the blastomeres in the 4-cell stage show clear differ-
ences not only in the levels of histone methylation, but also
in their transcriptional activiy when they develop without
being perturbed. However (third), the cells undergo a redirec-
tion of cell fate when a histone methyltransferase is overex-
pressed, indicating that they can readapt. Finally, the
environment in which cells develop seems to be crucial for
completing development and somehow the remaining cells in
the embryo could compensate provided they are somehow
different from each other. It is also important to note that a
4-cell stage mouse embryo might correspond to a very different
developmental stage than a 4-cell embryo in other mammalian
species, as illustrated by the differences in the onset of genome
activation between them. Indeed, PGD is most often performed
at the 8-cell stage and some reports document a better rate of
development when 6-to- 9-cell stage embryos are diagnosed,
as opposed to 3-to- 4-cell stage embryos (Wang et al., 2007).
Moreover, the effects of in vitro fertilization procedures and
culture on embryonic development are also extremely import-
ant, as they have been shown to alter epigenetic information in
the mouse (Li et al., 2005).
As a ﬁnal consideration, I would like to leave the reader with
an open perspective of some ongoing questions in the ﬁeld.
Although there are strong indications that epigenetic mechan-
isms are involved in cell fate determination, we are still far
from establishing a direct link between an epigenetic mark(s)
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Much work is still to be done to determine how these mechan-
isms are set in play upon fertilization and how they are trans-
mitted during subsequent cleavage stages. Also, what other
epigenetic marks contribute to the inheritability of cell fate
decisions? How do these marks relate to and inﬂuence each
other? Are different lineage-speciﬁc genes marked by a differ-
ent combination(s) of epigenetic marks? Do the marking of
these genes occur at different stages of development? It is
also tempting to expand these notions into the stem cell ﬁeld
and question whether these mechanisms would also underlie
the intrinsic self renewal ability of adult stem cells and their
potential to differentiate into other cell types. The exquisite
complexity and richness of chromatin-regulated events in the
early embryo will certainly be the subject of exciting research
in the future.
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